The science of Durban, AIDS 2016
Date
Authors
Beyrer, Chris
Shishana, Olive
Baral, Stefan D
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons
Abstract
The science presented at the 21st International AIDS Conference in Durban, South Africa, in July 2016,
addressed the state of the field across basic, clinical, prevention, law and policy and implementation science.
The AIDS response has seen remarkable achievements in scientific advances, in translation of those
advances into prevention, treatment and care for affected individuals and communities, and in large scale implementation –
reaching 18 million people with antiviral therapy by mid-year 2016. Yet incident HIV infections in adults remain stubbornly stable
and are increasing in some regions and among adolescents and adults in some key populations, challenging current science, policy
and programming. There have been important advances in both preventive vaccines and in cure research, but both areas require
ongoing investment and innovation. Clinical research has flourished with new agents, regimens, delivery modes and diagnostics
but has been challenged by aging and increasingly complex patient populations, long-term adherence challenges, co-infections
and co-morbidities, and unresolved issues in TB management and epidemic control. It is an extraordinary period of innovation in
prevention, yet the promise of new tools and combination approaches have yet to deliver epidemic HIV control.
Description
Keywords
AIDS (Disease), AIDS (Disease) - Treatment, AIDS (Disease) - Prevention, AIDS (Disease) - Social aspects, AIDS (Disease) - Patients - Civil rights
Citation
ISI 2017